Related Experiment Video
Updated: Jul 4, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Valproate teratogenicity and epilepsy syndrome.
Edward B Bromfield1, Barbara A Dworetzky, Diego F Wyszynski
1Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. ebromfield@partners.org
Epilepsia
|June 19, 2008
Summary
Maternal use of valproate (VPA) medication during pregnancy increases the risk of congenital malformations. The study suggests VPA itself, not the underlying epilepsy condition, is linked to this elevated risk in fetuses.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Teratology
Background:
- Maternal valproate (VPA) use during pregnancy is a known risk factor for congenital malformations.
- Epilepsy syndromes often treated with VPA have presumed genetic origins, raising questions about genetic contributions to malformation risk.
Purpose of the Study:
- To investigate whether the underlying epilepsy type or maternal genetic background influences the risk of congenital malformations in fetuses exposed to valproate.
- To differentiate the teratogenic risk associated with valproate itself versus the epilepsy condition being treated.
Main Methods:
- Review of medical records and telephone questionnaires from the North American Antiepileptic Drug Pregnancy Registry.
- Classification of VPA treatment indications into idiopathic generalized epilepsy (IGE), partial epilepsy (PE), nonclassifiable epilepsy (NCE), and not epilepsy (NE).
- Analysis of malformation rates across different epilepsy classifications in 284 VPA-exposed pregnancies.
Main Results:
- Overall, 11.0% (30/284) of VPA-exposed pregnancies resulted in malformations.
- Malformation rates were similar across epilepsy classifications: IGE (12%), PE (14%), NCE (9%), and NE (8%).
- A trend suggested increased malformation risk with higher VPA doses (p = 0.07).
Conclusions:
- Valproate (VPA) exposure, rather than the specific underlying genetic epilepsy syndrome, appears to be the primary factor associated with elevated congenital malformation risk.
- The findings support that VPA's teratogenic effects are independent of the maternal genetic background related to idiopathic epilepsies.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...